| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Carcinogenesis |
Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115 [J. D., S. S., N. N., R. R-G., W. S., M. L., M. B.], and Departments of Medicine [J. D., W. S., M. B.] and Pathology [S. S., M. L.], Brigham and Womens Hospital, Boston, Massachusetts 02115
Carcinogenesis involves a multistep process whereby a normal healthy cell undergoes both immortalization and oncogenesis to become fully transformed. Immortalization results from the subversion of critical cell cycle regulatory checkpoints, thereby allowing a cell to extend its finite life span and to maintain telomeric length. Oncogenesis is the manifestation of additional genetic events that are capable of conferring upon the cell an actual growth advantage. Such an advantage may relieve a cell of its normal requirements for a particular growth factor or may enhance the ability of a cell to proliferate outside of its normal microenvironment. To further investigate this multistep process, we developed an immortalized mammary epithelial cell line by overexpressing the catalytic subunit of telomerase (human telomerase reverse transcriptase) in primary human mammary epithelial cell lines. We present evidence that the overexpression of human telomerase reverse transcriptase was sufficient to extend the life span of the cells and allow for additional events that lead to immortalization. The result was the establishment of an IMEC line. Biochemical analysis of these cells indicates a basal epithelial phenotype with expression of high molecular weight cytokeratins. We show that continued growth of the IMECs is rigorously dependent upon both insulin and epidermal growth factor, and that the mitogenic effects of these factors on the IMECs are mediated in part by AKT. In addition, IMECs express the p53 family member 
N-p63-
, which is found in basal epithelial cells of many tissues and has been implicated as playing an essential role in normal epithelial development. Our studies suggest that the immortalization of basal epithelial cells of the mammary gland may be an early step in the initiation of a subset of breast cancers with a basal epithelial phenotype.
This article has been cited by other articles:
|
|
 |
|
  X. Liu, L. F. Sempere, F. Galimberti, S. J. Freemantle, C. Black, K. H. Dragnev, Y. Ma, S. Fiering, V. Memoli, H. Li, et al. Uncovering Growth-Suppressive MicroRNAs in Lung Cancer Clin. Cancer Res., February 15, 2009; 15(4): 1177 - 1183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Li, S. Singh, P. Cherukuri, H. Li, Z. Yuan, L. W. Ellisen, B. Wang, D. Robbins, and J. DiRenzo Reciprocal Intraepithelial Interactions Between TP63 and Hedgehog Signaling Regulate Quiescence and Activation of Progenitor Elaboration by Mammary Stem Cells Stem Cells, May 1, 2008; 26(5): 1253 - 1264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Aaltonen, C. Blomqvist, R.-M. Amini, H. Eerola, K. Aittomaki, P. Heikkila, and H. Nevanlinna Familial Breast Cancers without Mutations in BRCA1 or BRCA2 Have Low Cyclin E and High Cyclin D1 in Contrast to Cancers in BRCA Mutation Carriers Clin. Cancer Res., April 1, 2008; 14(7): 1976 - 1983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Stull, V. Pai, A. J. Vomachka, A. M. Marshall, G. A. Jacob, and N. D. Horseman Mammary gland homeostasis employs serotonergic regulation of epithelial tight junctions PNAS, October 16, 2007; 104(42): 16708 - 16713. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Konishi, B. Karakas, A. M. Abukhdeir, J. Lauring, J. P. Gustin, J. P. Garay, Y. Konishi, E. Gallmeier, K. E. Bachman, and B. H. Park Knock-in of Mutant K-ras in Nontumorigenic Human Epithelial Cells as a New Model for Studying K-ras Mediated Transformation Cancer Res., September 15, 2007; 67(18): 8460 - 8467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. H. Cowling, C. M. D'Cruz, L. A. Chodosh, and M. D. Cole c-Myc Transforms Human Mammary Epithelial Cells through Repression of the Wnt Inhibitors DKK1 and SFRP1 Mol. Cell. Biol., July 15, 2007; 27(14): 5135 - 5146. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. H. Cowling and M. D. Cole The Myc Transactivation Domain Promotes Global Phosphorylation of the RNA Polymerase II Carboxy-Terminal Domain Independently of Direct DNA Binding Mol. Cell. Biol., March 15, 2007; 27(6): 2059 - 2073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Li, P. Cherukuri, N. Li, V. Cowling, M. Spinella, M. Cole, A. K. Godwin, W. Wells, and J. DiRenzo Nestin Is Expressed in the Basal/Myoepithelial Layer of the Mammary Gland and Is a Selective Marker of Basal Epithelial Breast Tumors Cancer Res., January 15, 2007; 67(2): 501 - 510. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. van Diest, P. van der Groep, and E. van der Wall EGFR Expression Predicts BRCA1 Status in Patients with Breast Cancer Clin. Cancer Res., January 15, 2006; 12(2): 670 - 670. [Full Text] [PDF]
|
|
|
|
|
|
S. R. Lakhani Reply to the Letter to the Editor by van Diest, et al Clin. Cancer Res., January 15, 2006; 12(2): 671 - 671. [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Alvero, D. A. Fishman, M. B. Qumsiyeh, M. Garg, B. M. Kacinski, and E. Sapi Telomerase Prolongs the Lifespan of Normal Human Ovarian Surface Epithelial Cells Without Inducing Neoplastic Phenotype Reproductive Sciences, December 1, 2004; 11(8): 553 - 561. [Abstract] [PDF]
|
|
|
|
 |
|
 S.-i. Kurata, T. Okuyama, M. Osada, T. Watanabe, Y. Tomimori, S. Sato, A. Iwai, T. Tsuji, Y. Ikawa, and I. Katoh p51/p63 Controls Subunit {alpha}3 of the Major Epidermis Integrin Anchoring the Stem Cells to the Niche J. Biol. Chem., November 26, 2004; 279(48): 50069 - 50077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. van der Groep, A. Bouter, R. van der Zanden, F. H. Menko, H. Buerger, R. H.M. Verheijen, E. van der Wall, and P. J. van Diest Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer J Natl Cancer Inst, May 5, 2004; 96(9): 712 - 713. [Full Text] [PDF]
|
|
|
|
 |
|
 F. McKeon p63 and the epithelial stem cell: more than status quo? Genes & Dev., March 1, 2004; 18(5): 465 - 469. [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Hahn Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer J. Clin. Oncol., May 15, 2003; 21(10): 2034 - 2043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-o. Piboonniyom, S. Duensing, N. W. Swilling, J. Hasskarl, P. W. Hinds, and K. Munger Abrogation of the Retinoblastoma Tumor Suppressor Checkpoint During Keratinocyte Immortalization Is Not Sufficient for Induction of Centrosome-mediated Genomic Instability Cancer Res., January 15, 2003; 63(2): 476 - 483. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
